Results 171 to 180 of about 6,714 (194)
Some of the next articles are maybe not open access.
Pathogenic UBA1 variants define a subset of relapsing polychondritis
Nature Reviews Rheumatology, 2021Two new studies have identified mutations in UBA1 associated with the newly identified condition VEXAS syndrome in cohorts of patients with relapsing polychondritis, supporting the concept that relapsing polychondritis is more than one disease.
exaly +3 more sources
The functional role of UBA1 cysteine-278 in ubiquitination
Biochemical and Biophysical Research Communications, 2012Although total UBA1 levels were unchanged, after oxidation for 60 min, we observed dramatic changes in the levels of BIAM-labeled UBA1 in both the membrane and cytosol fractions that suggested oxidative stress induces translocation of UBA1 from the cytosol to the membrane.
Ung, Yang +3 more
openaire +2 more sources
Mutation du gène UBA1 dans l’artérite à cellules géantes
La Revue de Médecine Interne, 2021Introduction Le syndrome VEXAS (vacuoles, enzyme E1, liee a l’X, auto-inflammatoire, somatique), est associe a des mutations somatiques affectant la methionine-41 (pMet41) dans le gene de l’Ubiquitin-like modifier activating enzyme 1 (UBA1) situe sur le chromosome X [1] , [2] .
J. Rossignol +11 more
openaire +1 more source
Zebrafish Uba1 Degrades IRF3 through K48-Linked Ubiquitination to Inhibit IFN Production
The Journal of Immunology, 2021Abstract Fish IFN regulatory factor 3 (IRF3) is a crucial transcription factor in the IFN activation signaling pathway, which leads to IFN production and a positive cycle. Unrestricted IFN expression results in hyperimmune responses and therefore, IFN must be tightly regulated.
Dan-Dan Chen +7 more
openaire +2 more sources
Annals of the Rheumatic Diseases, 2021
To determine clinical and genetic features of individuals with relapsing polychondritis (RP) likely caused by pathogenic somatic variants in ubiquitin-like modifier activating enzyme 1 (UBA1).Fourteen patients with RP who met the Damiani and Levine criteria were recruited (12 men, 2 women; median onset age (IQR) 72.1 years (67.1-78.0)).
Naomi Tsuchida +12 more
openaire +2 more sources
To determine clinical and genetic features of individuals with relapsing polychondritis (RP) likely caused by pathogenic somatic variants in ubiquitin-like modifier activating enzyme 1 (UBA1).Fourteen patients with RP who met the Damiani and Levine criteria were recruited (12 men, 2 women; median onset age (IQR) 72.1 years (67.1-78.0)).
Naomi Tsuchida +12 more
openaire +2 more sources
UBA1 Mutations Identify a Rare but Distinct Subtype of Myelodysplastic Syndromes
Blood, 2023Background Mutations in UBA1 are associated with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, an adult-onset inflammatory disorder (Beck DB et al. NEJM 2020). Approximately 40% of VEXAS patients are also diagnosed with myelodysplastic syndromes (MDS).
Sirenko, M +52 more
openaire +2 more sources
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome
Seminars in Hematology, 2021VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a newly characterized syndrome with underlying somatic UBA1 mutations in myeloid cells linking hematologic disease with autoinflammatory rheumatologic disorders. Hematologic abnormalities, particularly peripheral blood cytopenia(s) may prompt bone marrow evaluation in patients with ...
Nisha Patel +2 more
openaire +2 more sources
UBA1 gene mutation in giant cell arteritis
Clinical Rheumatology, 2022Julien Rossignol +11 more
openaire +2 more sources
Downregulation of UBA1 in Myelodysplastic Syndrome
Blood, 2022Yue Wei +7 more
openaire +1 more source
Investigating UBA1 distribution and its relevance to Spinal Muscular Atrophy
The FASEB Journal, 2017Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease characterized by the degeneration of lower motor neurons. SMA is the most common genetic cause of infant mortality and is caused by a homozygous deletion of the Survival Motor Neuron 1 gene (SMN1). There is currently no effective therapy.
Maani, Amr +2 more
openaire +2 more sources

